Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



The Burnham Institute for Medical Research

Award Total: $12,595,718 # of Grants: 40
Investigators

AdrienneCoxPh.D. - LawrenceQuilliam - YoshinoriKohwiPh.D. - Xiao-KunZhangPh.D. - Xiao-KunZhangPh.D. - Xiao-KunZhangPh.D. - Xiao-KunZhangPh.D. - GeorgeSteele-PerkinsPh.D. - HudsonFreezePh.D. - StevenFrischPh.D. - Li-TaoZhongM.D., Ph.D. - WandaReynoldsPh.D. - ShahrzadNourainiPh.D. - WadihArapM.D., Ph.D. - ZhihuaXiePh.D. - Shu-ichiMatsuzawaPh.D. - JeffreySmithPh.D. - JeffreySmithPh.D. - JohnReedM.D., Ph.D. - MagnusPfahlPh.D. - ElenaPasqualePh.D. - ShiHuangPh.D. - KristiinaVuoriM.D., Ph.D. - KristiinaVuoriM.D., Ph.D. - KristiinaVuoriM.D., Ph.D. - YoungsooKimPh.D. - ErkkiRuoslahtiM.D., Ph.D. - ErkkiRuoslahtiM.D., Ph.D. - ErkkiRuoslahtiM.D., Ph.D. - Iande BellePh.D. - TaroKawaiPh.D. - WilliamStallcupPh.D. - Tsung-HsienChuangPh.D. - SivaKolluriPh.D. - CharlesSpruckPh.D. - HuZhouPh.D. - NabilArrachPh.D. - PauloGodoiPh.D. - RenataSanoPhD - ErikaLisabethPh.D. - Ying ChenHouPh.D - NicholasCosfordPh.D. -
Grants

2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth 1995 (Cycle 4) $149,221
Cardiovascular Disease Inno Dev & Exp Awards (IDEAS)

A novel therapeutic target for stroke 1997 (Cycle 6) $72,310
Cardiovascular Disease Postdoctoral Fellowship Awards

A novel lung tumor suppressor 1997 (Cycle 6) $144,788
Cancer Inno Dev & Exp Awards (IDEAS)

Does nicotine inhibit anticancer activities of Vitamin A? 1997 (Cycle 6) $788,808
Cancer Research Project Awards

BAG-1, a unique gene involved in smoking-associated cancers 1998 (Cycle 7) $75,060
Cancer Postdoctoral Fellowship Awards

A study of Bax, a gene involved in killing tumor cells 1998 (Cycle 7) $75,060
Cancer Postdoctoral Fellowship Awards

Toxic compounds targeted to lung tumor blood vessels 1998 (Cycle 7) $144,300
Cancer Inno Dev & Exp Awards (IDEAS)

Suppressor genes of lung cancer 1998 (Cycle 7) $859,254
Cancer Research Project Awards

Molecular Mechanism of Retinoic Acid Action 1992 (Cycle 1) $75,600
General Biomedical Science Postdoctoral Fellowship Awards

Studies in Genotoxicity of Tobacco-Related Carcinogens 1992 (Cycle 1) $288,000
Cancer New Investigator Awards

Ras Prenylation, Cholesterol Biosynthesis and Lung Cancer 1993 (Cycle 2) $49,960
Cancer Postdoctoral Fellowship Awards

Involvement of RAS and Krev-1 in Lung Cancer 1993 (Cycle 2) $50,552
Cancer Postdoctoral Fellowship Awards

Analysis of Retinoid Mediated Anti-cancer Activities 1993 (Cycle 2) $757,415
Cancer Research Project Awards

The Role of TGF-B1 In Intimal Hyperplasia 1994 (Cycle 3) $66,448
Cardiovascular Disease Inno Dev & Exp Awards (IDEAS)

Cell Adhesion Receptors in Atherogenesis 1994 (Cycle 3) $170,341
Cardiovascular Disease Research Project Awards

Function of Rb-interacting zinc-finger protein, "RIZ" 1995 (Cycle 4) $32,400
Cancer Postdoctoral Fellowship Awards

Preneoplastic Lesions and Polarity Changes in Lung Epithelia 1995 (Cycle 4) $142,731
Cancer Inno Dev & Exp Awards (IDEAS)

Siah-family proteins in lung cancer 2000 (Cycle 9) $74,560
Cancer Postdoctoral Fellowship Awards

To identify Egr-1 target genes important in pulmonary diseas 2000 (Cycle 9) $430,539
Pulmonary Disease New Investigator Awards

Overcoming drug resistance in small cell lung cancer 2001 (Cycle 10) $141,340
Cancer Inno Dev & Exp Awards (IDEAS)

ZIP kinase and lung cancer 2001 (Cycle 10) $65,854
Cancer Postdoctoral Fellowship Awards

Smoking-induced oxidant stress & platelet integrin alpha.... 2001 (Cycle 10) $801,893
Cardiovascular Disease Research Project Awards

Novel agents for apoptosis of lung cancer 2002 (Cycle 11) $787,977
Cancer Research Project Awards

Integrins and drug resistance in small cell lung cancer 2003 (Cycle 12) $780,144
Cancer Research Project Awards

Targeting Hypoxia-inducible Factor to Treat Lung Cancer 2003 (Cycle 12) $509,490
Cancer New Investigator Awards

IAP Antagonists for lung cancer treatment 2004 (Cycle 13) $727,658
Cancer Research Project Awards

Novel Approaches to Lung Cancer Research 2006 (Cycle 15) $189,486
Cancer Inno Dev & Exp Awards (IDEAS)

Nicotine-dependent recruitment of vascular progenitor cells 2006 (Cycle 15) $799,907
Cardiovascular Disease Research Project Awards

How omega-3 fatty acids prevent or slow cancer 2006 (Cycle 15) $74,808
Cancer Postdoctoral Fellowship Awards

Targeting anti-apoptotic Bcl-2 family members in lung cancer 2007 (Cycle 16) $75,000
Cancer Postdoctoral Fellowship Awards

Vitamin A derivatives as antagonists of nicotine effects 2004 (Cycle 13) $670,085
Cancer Research Project Awards

Control of cellular self-digestion in lung tumorigenesis 2009 (Cycle 18) $135,000
Cancer Postdoctoral Fellowship Awards

Role of EphA3 receptor mutations in lung cancer 2009 (Cycle 18) $477,500
Cancer Exploratory/Developmental Award

Modulating TLR9 Activation for Lung Cancer Therapy 2007 (Cycle 16) $415,463
Cancer Research Project Awards

Impact of MPO in Tobacco-related Cardiovascular Disease 2007 (Cycle 16) $267,555
Cardiovascular Disease Research Project Awards

Engineering Salmonella for lung cancer therapy 2007 (Cycle 16) $104,050
Cancer New Investigator Awards

Fbxo2: a master regulator of lung cancer metastasis? 2010 (Cycle 19) $477,500
Cancer Exploratory/Developmental Award

Mapping the EphA Receptor Landscape in Lung Cancer 2011 (Cycle 20) $98,299
Cancer Postdoctoral Fellowship Awards

Metabolic stress & cell survival in lung cancer 2012 (Cycle 21) $89,208
Early Diagnosis/Pathogenesis Postdoctoral Fellowship Awards

mGlu7 activators as drug candidates for nicotine dependence 2016 (Cycle 25) $460,154
Neuroscience of Nicotine Addiction and Treatment High Impact Pilot Award